Hirofumi Mukai

Hirofumi Mukai

UNVERIFIED PROFILE

Are you Hirofumi Mukai?   Register this Author

Register author
Hirofumi Mukai

Hirofumi Mukai

Publications by authors named "Hirofumi Mukai"

Are you Hirofumi Mukai?   Register this Author

100Publications

1850Reads

14Profile Views

Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.

Breast Cancer 2019 09 24;26(5):637-650. Epub 2019 May 24.

Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-019-00970-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694088PMC
September 2019

Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.

Breast Cancer 2019 09;26(5):651

Kyoto University Graduate School of Medicine, 54 Kawaracho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-019-00984-1DOI Listing
September 2019

DNA methylation marker to estimate the breast cancer cell fraction in DNA samples.

Med Oncol 2018 Sep 14;35(11):147. Epub 2018 Sep 14.

Division of Epigenomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-018-1207-3DOI Listing
September 2018

[Clinical Practice of Carcinoma of Unknown Primary].

Gan To Kagaku Ryoho 2018 Jun;45(6):891-893

Division of Breast and Medical Oncology, National Cancer Center Hospital East.

View Article

Download full-text PDF

Source
June 2018

Advances in chemotherapy for HER2-negative metastatic breast cancer.

Chin Clin Oncol 2018 Jun;7(3):26

Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2018.06.01DOI Listing
June 2018

The Impact of Treatment Preferences in Second-Line Chemotherapy on the Prognosis of HER2-Negative Metastatic Breast Cancer.

Oncology 2017 24;93(5):315-322. Epub 2017 Aug 24.

Division of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000479033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804827PMC
March 2018

Rainbow of KIBOU (ROK) study: a Breast Cancer Survivor Cohort in Japan.

Breast Cancer 2018 Jan 25;25(1):60-67. Epub 2017 May 25.

Division of Health Sociology, Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-017-0784-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741795PMC
January 2018

Inter-observer agreement among pathologists in grading the pathological response to neoadjuvant chemotherapy in breast cancer.

Breast Cancer 2018 Jan 30;25(1):118-125. Epub 2017 Aug 30.

Diagnostic Pathology Section, Clinical Laboratory Division, National Cancer Center Hospital, 5-1-1, Tuskiji, Chuo-Ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-017-0799-3DOI Listing
January 2018

A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors.

Invest New Drugs 2017 06 4;35(3):307-314. Epub 2017 Jan 4.

Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa City, Chiba Prefecture, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-016-0422-z
Publisher Site
http://dx.doi.org/10.1007/s10637-016-0422-zDOI Listing
June 2017

Post-mastectomy radiation therapy without usage of a bolus may be a reasonable option.

J Radiat Res 2017 Jan 15;58(1):66-70. Epub 2016 Jul 15.

Division of Radiation Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jrr/rrw055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321177PMC
January 2017

Long-term combination chemotherapy using eribulin and trastuzumab for three patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Int Cancer Conf J 2016 Oct 21;5(4):178-182. Epub 2016 Jun 21.

6Department of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577 Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13691-016-0253-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498262PMC
October 2016

Evaluation of oral care to prevent oral mucositis in estrogen receptor-positive metastatic breast cancer patients treated with everolimus (Oral Care-BC): randomized controlled phase III trial.

Jpn J Clin Oncol 2016 Sep 30;46(9):879-82. Epub 2016 Jun 30.

Department of Clinical Oral Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyw077DOI Listing
September 2016

Prospective cohort study of febrile neutropenia in breast cancer patients with neoadjuvant and adjuvant chemotherapy: CSPOR-BC FN study.

Jpn J Clin Oncol 2016 Jul 9;46(7):692-5. Epub 2016 May 9.

Graduate School of Medicine, Department of Clinical Oncology, Yokohama City University, Yokohama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyw045DOI Listing
July 2016

The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2015 edition.

Breast Cancer 2016 May 16;23(3):378-90. Epub 2016 Feb 16.

Department of Oncology/Hematology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-016-0672-9DOI Listing
May 2016

The Japanese Breast Cancer Society clinical practice guidelines for pathological diagnosis of breast cancer, 2015 edition.

Breast Cancer 2016 May 25;23(3):391-9. Epub 2016 Feb 25.

Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-016-0675-6DOI Listing
May 2016

Effect of food on the pharmacokinetics of TAS-102 and its efficacy and safety in patients with advanced solid tumors.

Cancer Sci 2016 May 28;107(5):659-65. Epub 2016 Mar 28.

Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12912DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970833PMC
May 2016

The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition.

Breast Cancer 2016 May 26;23(3):367-77. Epub 2016 Feb 26.

Department of General and Breast Surgery, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-016-0671-xDOI Listing
May 2016

The Japanese Breast Cancer Society clinical practice guidelines for screening and imaging diagnosis of breast cancer, 2015 edition.

Breast Cancer 2016 May 6;23(3):357-66. Epub 2016 Apr 6.

Department of Oncology/Hematology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-016-0674-7DOI Listing
May 2016

Quality evaluation of medical care for breast cancer in Japan.

Int J Qual Health Care 2016 Feb 13;28(1):110-3. Epub 2015 Dec 13.

Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/intqhc/mzv109DOI Listing
February 2016

Stratifying the outcome after neoadjuvant treatment using pathological response classification by the Japanese Breast Cancer Society.

Breast Cancer 2016 Jan 30;23(1):73-77. Epub 2015 Sep 30.

Division of Breast Surgery, Saitama Cancer Center, Saitama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-015-0640-9DOI Listing
January 2016

Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.

Cancer Chemother Pharmacol 2015 Oct 8;76(4):739-50. Epub 2015 Aug 8.

Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2826-4DOI Listing
October 2015

Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer.

Oncology 2015 14;88(6):377-84. Epub 2015 Jan 14.

Department of Medical Oncology, Musashino Red Cross Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000369904DOI Listing
August 2015

Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31.

J Clin Oncol 2015 May 16;33(14):1574-83. Epub 2015 Mar 16.

Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver; Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia; Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec; Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston; Susan Dent, Ottawa Health Research Institute, Ottawa; Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto; Timothy J. Whelan, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario; Katia Tonkin, Cross Cancer Institute, Edmonton, Alberta, Canada; Frances M. Boyle, Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia; Bella Kaufman, Sheba Medical Centre, Tel Hashomer; Shulamith Rizel, Rabin Medical Center, Petach Tikva, Israel; Alexey Manikhas, City Clinical Oncological Dispensery, St Petersburg; Sergei Tjulandin, Russian Cancer Research Center, Moscow; Rustem Khasanov, Clinical Oncology Dispensary, Kazan, Russia; Angelo Di Leo, Sandro Pitgliani Medical Oncology Unit, Prato, Italy; Miguel Martin, Servicio Oncologia Hospital Gregorio Marañon, Madrid, Spain; Lee S. Schwartzberg, West Clinic, Memphis, TN; Arnd Nusch, Praxis, Velbert, Germany; Robert E. Coleman, Weston Park Hospital, Cancer Research Centre, Sheffield, United Kingdom; Hirofumi Mukai, National Cancer Center Hospital East, Kashiwa-shi, Japan; Anne P. Connor, GlaxoSmithKline, Collegeville, PA; and Sergio L. Santillana, GlaxoSmithKline, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/14/1574.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.56.9590
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.9590DOI Listing
May 2015

Phase 1 combination study of eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer.

Invest New Drugs 2015 Feb 23;33(1):119-27. Epub 2014 Sep 23.

Department of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0161-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295025PMC
February 2015

The Japanese Breast Cancer Society clinical practice guideline for radiotherapy of breast cancer.

Breast Cancer 2015 Jan 15;22(1):49-58. Epub 2014 Jul 15.

Department of Radiation Oncology, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-014-0548-9DOI Listing
January 2015

The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancer.

Breast Cancer 2015 Jan 15;22(1):59-65. Epub 2014 Jul 15.

Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s12282-014-0549
Web Search
http://link.springer.com/content/pdf/10.1007/s12282-016-0675
Web Search
http://link.springer.com/10.1007/s12282-014-0549-8
Publisher Site
http://dx.doi.org/10.1007/s12282-014-0549-8DOI Listing
January 2015

The Japanese Breast Cancer Society clinical practice guideline for epidemiology and prevention of breast cancer.

Breast Cancer 2015 Jan 2;22(1):16-27. Epub 2014 Aug 2.

Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-014-0555-xDOI Listing
January 2015

The Japanese Breast Cancer Society Clinical Practice Guideline for screening and imaging diagnosis of breast cancer.

Breast Cancer 2015 Jan 2;22(1):28-36. Epub 2014 Aug 2.

Diagnostic Imaging Center, Kameda Kyobashi Clinic, 3-1-1 Kyobashi Chuo-ku, Tokyo Square Garden 4F, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-014-0557-8DOI Listing
January 2015

Japan Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer.

Breast Cancer 2015 Jan 5;22(1):37-48. Epub 2014 Aug 5.

Section of Breast and Endocrine Surgery, Department of Surgery, Kinki University Faculty of Medicine, 377-2 Onohigashi, Osakasayama, Osaka, 589-8511, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-014-0558-7DOI Listing
January 2015

The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer.

Breast Cancer 2015 Jan 9;22(1):5-15. Epub 2014 Sep 9.

Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-014-0563-xDOI Listing
January 2015

Survival outcome and reduction rate of Ki-67 between pre- and post-neoadjuvant chemotherapy in breast cancer patients with non-pCR.

Breast Cancer Res Treat 2014 Aug 9;147(1):95-102. Epub 2014 Aug 9.

Department of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3084-6DOI Listing
August 2014

Factors affecting enrollment in a randomized controlled trial for Japanese metastatic breast cancer patients (SELECT BC-FEEL)--a prospective study.

Jpn J Clin Oncol 2014 Jul 25;44(7):696-701. Epub 2014 May 25.

Department of Biostatistics/Epidemiology and Preventive Health Science, School of Health Science and Nursing, University of Tokyo, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyu065DOI Listing
July 2014

Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer.

Cancer Chemother Pharmacol 2014 Apr 1;73(4):703-10. Epub 2014 Feb 1.

National Cancer Center Hospital East, 6-5-1 Kashiwanoha Kashiwa-Shi, Chiba, 277-8577, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2394-zDOI Listing
April 2014

Prospective cohort study: whether or not patients benefit from participation itself in randomized-controlled trials (SELECT BC ECO).

Jpn J Clin Oncol 2014 Mar 27;44(3):296-9. Epub 2014 Jan 27.

*Division of Oncology/Hematology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa-shi, Chiba, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyt225DOI Listing
March 2014

Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer.

Asia Pac J Clin Oncol 2013 Dec 6;9(4):310-7. Epub 2012 Nov 6.

Division of Oncology and Hematology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933765PMC
December 2013

The current status and future perspectives of CSPOR-BC.

Breast Cancer 2013 Oct 28;20(4):287-90. Epub 2012 Jun 28.

Breast Center, Aihara Hospital, 3-4-30, Makiochi, Minoh, Osaka, 562-0004, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-012-0386-6DOI Listing
October 2013

The current status and future perspectives of clinical trial groups in Japan.

Authors:
Hirofumi Mukai

Breast Cancer 2013 Oct;20(4):285-6

Division of Oncology/Hematology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-013-0491-1DOI Listing
October 2013

First experience of active surveillance before systemic target therapy in patients with metastatic renal cell carcinoma.

Urology 2013 Jul;82(1):118-23

Division of Oncology and Hematology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2013.03.035DOI Listing
July 2013

Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival.

Oncology 2013 11;84(3):135-40. Epub 2012 Dec 11.

Divisions of Oncology/Hematology, National Cancer Center Hospital East, Kashiwa, Japan. mishihara @ clin.medic.mie-u.ac.jp

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000345321DOI Listing
March 2013

Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer.

Breast Cancer Res Treat 2013 Jan 27;137(1):203-12. Epub 2012 Nov 27.

Department of Oncology and Hematology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa city, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2344-6DOI Listing
January 2013

Eribulin mesylate in patients with refractory cancers: a Phase I study.

Invest New Drugs 2012 Oct 2;30(5):1926-33. Epub 2011 Sep 2.

Medical Oncology/Hematology, Kobe University Hospital and Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10637-011-9741
Web Search
http://link.springer.com/10.1007/s10637-011-9741-2
Publisher Site
http://dx.doi.org/10.1007/s10637-011-9741-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432792PMC
October 2012

Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: a new risk model for success from an analysis of 75 cases.

Int J Clin Oncol 2012 Oct 7;17(5):470-6. Epub 2011 Oct 7.

Division of Oncology and Hematology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-011-0312-5DOI Listing
October 2012

[Clinical evaluation of anti-cancer or targeted drugs and the optimal timing for changing therapeutics-breast cancer].

Authors:
Hirofumi Mukai

Gan To Kagaku Ryoho 2012 Oct;39(10):1458-61

Division of Oncology and Hematology, National Cancer Center Hospital East, Chiwa, Japan.

View Article

Download full-text PDF

Source
October 2012

[Principal strategy for metastatic breast cancer].

Nihon Rinsho 2012 Sep;70 Suppl 7:577-80

Division of Oncology and Hematology, National Cancer Center Hospital East.

View Article

Download full-text PDF

Source
September 2012

Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study.

Breast Cancer 2012 Jul 28;19(3):253-8. Epub 2011 Apr 28.

Department of Clinical Oncology and Chemotherapy, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-011-0270-9DOI Listing
July 2012

Prognostic impact of Ki-67 overexpression in subgroups categorized according to St. Gallen with early stage breast cancer.

Oncology 2011 13;81(5-6):345-52. Epub 2012 Jan 13.

Department of Oncology and Hematology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000334920DOI Listing
June 2012

Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1-4 years: N-SAS BC 03.

Breast Cancer Res Treat 2011 May 24;127(1):143-52. Epub 2011 Feb 24.

Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minami-umemoto-machi, Matsuyama, Ehime 791-0280, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1400-yDOI Listing
May 2011

Review of primary unknown cancer: cases referred to the National Cancer Center Hospital East.

Int J Clin Oncol 2010 Dec 11;15(6):578-82. Epub 2010 Aug 11.

Division of Oncology and Hematology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-010-0112-3DOI Listing
December 2010

Targeted therapy in breast cancer: current status and future directions.

Authors:
Hirofumi Mukai

Jpn J Clin Oncol 2010 Aug 8;40(8):711-6. Epub 2010 Apr 8.

Division of Oncology/Hematology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa-shi, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyq037DOI Listing
August 2010

Elderly breast cancer therapy: a Japanese experience.

Jpn J Clin Oncol 2010 Aug 29;40(8):717-21. Epub 2010 Apr 29.

Division of Oncology and Hematology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyq061DOI Listing
August 2010

Randomized study of taxane versus TS-1 in women with metastatic or recurrent breast cancer (SELECT BC).

Jpn J Clin Oncol 2010 Aug 12;40(8):811-4. Epub 2010 May 12.

Division of Oncology/Hematology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa-shi, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyq054DOI Listing
August 2010

Treatment strategy for HER2-positive breast cancer.

Authors:
Hirofumi Mukai

Int J Clin Oncol 2010 Aug 15;15(4):335-40. Epub 2010 Jul 15.

Division of Oncology/Hematology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-010-0107-0DOI Listing
August 2010

Safety and efficacy of a combination of docetaxel and cisplatin in patients with unknown primary cancer.

Am J Clin Oncol 2010 Feb;33(1):32-5

Division of Oncology and Hematology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31819ccc55DOI Listing
February 2010

Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer.

Int J Clin Oncol 2009 Oct 25;14(5):431-5. Epub 2009 Oct 25.

Division of Oncology/Hematology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-009-0898-zDOI Listing
October 2009

[Clinical diagnosis of primary unknown cancer-the present situation and problems].

Authors:
Hirofumi Mukai

Gan To Kagaku Ryoho 2009 Jun;36(6):915-7

Division of Chemotherapy, National Cancer Center Hospital East, Japan.

View Article

Download full-text PDF

Source
June 2009

Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors.

Cancer Sci 2008 Jul 12;99(7):1492-8. Epub 2008 May 12.

Oncology/Hematology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2008.00837.xDOI Listing
July 2008